Kroger Health has partnered with Myriad Genetics to launch a pilot program involving the GeneSight pharmacogenetic test for personalizing depression treatments.
Within this pilot, 500 Kroger pharmacies in five states will provide information about GeneSight PGx testing to members who have failed one or more antidepressant treatments. These members will receive information about testing through their pharmacists or in the mail. Those interested will be directed to speak to their healthcare provider to determine if testing is appropriate.
GeneSight analyzes 12 genes involved in people's ability to process 56 drugs for depression.